ScholarIQanswers from OpenAlex

Antinuclear antibodies positivity is a risk factor of recurrent pregnancy loss: A meta-analysis

PaperCitations, authors & open-access status

Antinuclear antibodies positivity is a risk factor of recurrent pregnancy loss: A meta-analysis is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Antinuclear antibodies positivity is a risk factor of recurrent pregnancy loss: A meta-analysis have?

ScholarIQcitation count

Antinuclear antibodies positivity is a risk factor of recurrent pregnancy loss: A meta-analysis has 56 citations in the OpenAlex counts ScholarIQ stores.

When was Antinuclear antibodies positivity is a risk factor of recurrent pregnancy loss: A meta-analysis published?

ScholarIQyear

Antinuclear antibodies positivity is a risk factor of recurrent pregnancy loss: A meta-analysis has 2020 year in the ScholarIQ index.

What is the open-access status of Antinuclear antibodies positivity is a risk factor of recurrent pregnancy loss: A meta-analysis?

ScholarIQoa status

Antinuclear antibodies positivity is a risk factor of recurrent pregnancy loss: A meta-analysis has hybrid oa status in the ScholarIQ index.

What is the DOI of Antinuclear antibodies positivity is a risk factor of recurrent pregnancy loss: A meta-analysis?

ScholarIQdoi

The DOI for Antinuclear antibodies positivity is a risk factor of recurrent pregnancy loss: A meta-analysis is on the source record.

What is the PMID of Antinuclear antibodies positivity is a risk factor of recurrent pregnancy loss: A meta-analysis?

ScholarIQpmid

The PMID for Antinuclear antibodies positivity is a risk factor of recurrent pregnancy loss: A meta-analysis is on the source record.

What is the OpenAlex record for Antinuclear antibodies positivity is a risk factor of recurrent pregnancy loss: A meta-analysis?

ScholarIQopenalex

The OpenAlex for Antinuclear antibodies positivity is a risk factor of recurrent pregnancy loss: A meta-analysis is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial